Cash & equivalents decreased 66.4%
Cash & equivalents changed -66.4% from the comparable as-filed period.
$220.3M→$74.0M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BIOA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt decreased 100.0%
Debt changed -100.0% from the comparable as-filed period.
$5.6M→$03 prior comparisons
Net income decreased 21.0%
Net income changed -21.0% from the comparable as-filed period.
-$21.6M→-$26.1M2 prior comparisons
Operating margin moved 16979 bp lower
Operating margin changed -16979 basis points from the comparable as-filed period.
-1026.99%→-1196.78%1 prior comparisons
Research & development increased 22.8%
Research & development changed +22.8% from the comparable as-filed period.
$19.8M→$24.4M3 prior comparisons
Stock-based compensation increased 32.2%
Stock-based compensation changed +32.2% from the comparable as-filed period.
$3.2M→$4.3M3 prior comparisons
Operating income decreased 18.4%
Operating income changed -18.4% from the comparable as-filed period.
-$24.8M→-$29.3M3 prior comparisons
Revenue increased 1.6%
Revenue changed +1.6% from the comparable as-filed period.
$2.4M→$2.5M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.